TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin episode artwork

EPISODE · Feb 13, 2021 · 27 MIN

TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin

from This Week in Virology · host Vincent Racaniello

In COVID-19 clinical update #49, Daniel Griffin discusses CDC guidelines on mask use, drop in test frequency in the US, resurgence of COVID-19 in Brazil, possible impact of Pfizer vaccine on viral load, EUA for bamlanivimab and etesevimab administered together, and preliminary results of Tocilizumab in hospitalized patients. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Resurgence of COVID-19 in Brazil (Lancet) Pfizer vaccine reduces viral load (medRxiv) EUA for bamlanivimab plus etesevimab (pdf) Tocilizumab in hospitalized patients (medRxiv) Bacterial superinfections in COVID-19 (Open For Inf Dis) Letters read on TWiV 719 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]

Episode metadata supplied by the publisher feed · Published Feb 13, 2021

Embed this episode

NOW PLAYING

TWiV 719: COVID-19 clinical update #49 with Dr. Daniel Griffin

0:00 27:41

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of This Week in Virology?

This episode is 27 minutes long.

When was this This Week in Virology episode published?

This episode was published on February 13, 2021.

Can I download this This Week in Virology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!